Guerbet press releases and media resources | Guerbet

Our Latest Press Releases

Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT

Read the article

Changes to the Composition of Guerbet’s Board of Directors

Read the article

Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)

Read the article

Webinar: Liver focal lesions: where do we stand with detection and interest of AI?

Guerbet announces appointment of Jared Houk as Commercial Vice President for North America

Read the article

Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol

Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol

Read the article

Sales as of September 30, 2021

Read the article

Indice vert CAHPP : Guerbet obtient le label A++

Guerbet contributes to the NH TherAguix IPO on Euronext Growth, a specialist in innovative biotechnologies for precision radiotherapy

Read the article

Revenue at June 30, 2020

2021 half-year results

Read the article

First-half 2021 revenue

First-half 2021 revenue

Read the article

Webinar: Liver focal lesions: where do we stand with detection and interest of AI?

Statement regarding compliance to the European Medical Device Regulation (Regulation (EU) 2017/745, MDR) May 26th, 2021

Read the article

David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group’s strategy

Marc Massiot appointed to Guerbet’s Board of Directors

Read the article

2018 revenue

Q1 2021 revenue

Read the article

3
4
5
6
Current page7
8
9
10
11